{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/35669120-6056-4c38-8f33-80df7112e8df/c54ac28f-8b81-4145-8542-5f5619560a65?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Sick Money (Pt 1): Exposing the drug companies' price gouging tactics","description":"<p>In the first of two episodes this week, we're taking a deep dive into the pharmaceutical industry. </p><p>How much does the medication you take actually cost? What if a company came along and bought the rights to a particular drug and started charging double, triple, or even 10,000 times as much for the same drugs? Today: how a company made millions by raising the price on drugs that should have cost pennies. </p><p><em>This podcast was brought to you thanks to the support of readers of The Times and The Sunday Times. Subscribe today and get one month free at: thetimes.co.uk/storiesofourtimes. </em></p><p><strong>Guest:</strong> Billy Kenber, investigations reporter, The Times.</p><p><strong>Host:</strong> David Aaronovitch.</p>","author_name":"The Times"}